Request Deal Involvement

SoftBank Vision Fund 2 led a $150m Series C funding round in Dewpoint Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Finsbury Glover Hering

pr advisors

Finsbury Glover Hering

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

Cooley

legal advisors

Cooley

or

Principals

DEWPOINT THERAPEUTICS

target

DEWPOINT THERAPEUTICS

SOFTBANK VISION FUND 2

bidder

SOFTBANK VISION FUND 2

GENERAL CATALYST PARTNERS

bidder

GENERAL CATALYST PARTNERS

MUBADALA CAPITAL

bidder

MUBADALA CAPITAL

3E BIOVENTURES CAPITAL

bidder

3E BIOVENTURES CAPITAL

MIRAE ASSET CAPITAL CO LTD

bidder

MIRAE ASSET CAPITAL CO LTD

NS INVESTMENT

bidder

NS INVESTMENT

BAYER AG

bidder

BAYER AG

POLARIS PARTNERS

bidder

POLARIS PARTNERS

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

MAVERICK VENTURES

bidder

MAVERICK VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - SoftBank Vision Fund 2 led a $150m Series C funding round in Dewpoint Therapeutics.